thank you
MDI is quite small, but also very cheap, and the balance sheet is very strong, with $75M cash. Growth is slowing somewhat. It is not overly exciting, but not problematic. INMD and LNTH we think both have good upside. Both are cheap, both are growing, and both have strong balance sheets, INMD in particular. They have been weak on deceleration of growth, but have not done anything 'wrong'. Some patience may be required, but we think both could do quite well in a different rate/market environment, and valuations are attractive.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in INMD, LNTH.